Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 2400 participants.
Also called NCT04562805
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,400 participants
- Registry
-
NCT04562805
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04562805. Randomized; single masking; primary purpose treatment. Start 2020-09-30 (actual); primary completion 2024-09-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
- Condition
- Coronary Artery Disease
- Condition
- Ischemic Heart Disease
- Intervention (Device)
- DynamX Bioadaptor
- Intervention (Device)
- Resolute Onyx
- Lead sponsor
- Elixir Medical Corporation
- Collaborator
- Uppsala University
Record details
- Record id
cardio:ct-nct04562805- Content hash
cbd46e1c7588e131e905ca37ec467928087057e4840d99cee454d76f71173df5